MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$34,488,000
EPS
-$1.53
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Revenue under licensing agreements
-
0*
0
0
Research and development expenses
25,468,000
20,100,500*
17,241,000
19,366,000
General and administrative expenses
11,202,000
8,409,000*
6,557,000
6,715,000
Total operating expenses
36,670,000
28,509,500*
23,798,000
26,081,000
Loss from operations
-36,670,000
-28,509,500*
-23,798,000
-26,081,000
Interest income
2,046,000
3,046,500*
2,739,000
2,928,000
Interest expense
0
2,000*
1,000
1,000
Other income
143,000
-376,500*
149,000
1,212,000
Other expense
7,000
56,000*
42,000
74,000
Net loss
-34,488,000
-25,897,500
-20,953,000
-22,016,000
Basic EPS
-1.53
-1.19
-0.99
-1.05
Diluted EPS
-1.53
-1.19
-0.99
-1.05
Basic Average Shares
22,552,032
21,755,040
21,168,431
21,055,378
Diluted Average Shares
22,552,032
21,755,040
21,168,431
21,055,378
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$34,488,000
(-56.65%↓ Y/Y)
Interest income
$2,046,000
(-30.12%↓ Y/Y)
Other income
$143,000
(-88.20%↓ Y/Y)
Loss from operations
-$36,670,000
(-40.60%↓ Y/Y)
Other expense
$7,000
(-90.54%↓ Y/Y)
Total operating
expenses
$36,670,000
(40.60%↑ Y/Y)
Research and development
expenses
$25,468,000
(31.51%↑ Y/Y)
General and
administrative expenses
$11,202,000
(66.82%↑ Y/Y)
Buy us a coffee
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)